119 related articles for article (PubMed ID: 28685354)
21. Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.
Otsubo K; Kishimoto J; Kenmotsu H; Minegishi Y; Ichihara E; Shiraki A; Kato T; Atagi S; Horinouchi H; Ando M; Kondoh Y; Kusumoto M; Ichikado K; Yamamoto N; Nakanishi Y; Okamoto I
Clin Lung Cancer; 2018 Jan; 19(1):e5-e9. PubMed ID: 28687482
[TBL] [Abstract][Full Text] [Related]
22. Brain metastases from colorectal cancer: characteristics and management.
Mege D; Sans A; Ouaissi M; Iannelli A; Sielezneff I
ANZ J Surg; 2018 Mar; 88(3):140-145. PubMed ID: 28687024
[TBL] [Abstract][Full Text] [Related]
23. Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
Magnes T; Melchardt T; Weiss L; Mittermair C; Neureiter D; Klieser E; Gampenrieder S; Moser G; Gaggl A; Greil R; Egle A
PLoS One; 2017; 12(7):e0180995. PubMed ID: 28686697
[TBL] [Abstract][Full Text] [Related]
24. Prediction of outcome after curative surgery for colorectal cancer: preoperative haemoglobin, C-reactive protein and albumin.
Egenvall M; Mörner M; Martling A; Gunnarsson U
Colorectal Dis; 2018 Jan; 20(1):26-34. PubMed ID: 28685921
[TBL] [Abstract][Full Text] [Related]
25. The safety of ramucirumab for the treatment of colorectal cancer.
Noguerido A; Mulet-Margalef N; Matos I; Ros J; Argilés G; Élez E; Tabernero J
Expert Opin Drug Saf; 2018 Sep; 17(9):945-951. PubMed ID: 30073902
[TBL] [Abstract][Full Text] [Related]
26. A Phase I Study of S-1-based Concurrent Chemoradiotherapy Followed by Gemcitabine and S-1 in Metastatic Pancreatic Adenocarcinoma.
Yang SH; Shao YY; Lin CC; Kuo SH; Cheng AL; Yeh KH
Anticancer Res; 2018 Aug; 38(8):4805-4812. PubMed ID: 30061252
[TBL] [Abstract][Full Text] [Related]
27. A Small-molecule Kinase Inhibitor, CEP-1347, Inhibits Survivin Expression and Sensitizes Ovarian Cancer Stem Cells to Paclitaxel.
Togashi K; Okada M; Yamamoto M; Suzuki S; Sanomachi T; Seino S; Yamashita H; Kitanaka C
Anticancer Res; 2018 Aug; 38(8):4535-4542. PubMed ID: 30061219
[TBL] [Abstract][Full Text] [Related]
28. First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.
Aranda E; García-Alfonso P; Benavides M; Sánchez Ruiz A; Guillén-Ponce C; Safont MJ; Alcaide J; Gómez A; López R; Manzano JL; Méndez Ureña M; Sastre J; Rivera F; Grávalos C; García T; Martín-Valadés JI; Falcó E; Navalón M; González Flores E; Ma García Tapiador A; Ma López Muñoz A; Barrajón E; Reboredo M; García Teijido P; Viudez A; Cárdenas N; Díaz-Rubio E;
Eur J Cancer; 2018 Sep; 101():263-272. PubMed ID: 30054049
[TBL] [Abstract][Full Text] [Related]
29. Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study).
Nakayama G; Mitsuma A; Sunagawa Y; Ishigure K; Yokoyama H; Matsui T; Nakayama H; Nakata K; Ishiyama A; Asada T; Umeda S; Ezaka K; Hattori N; Takami H; Kobayashi D; Tanaka C; Kanda M; Yamada S; Koike M; Fujiwara M; Fujii T; Murotani K; Ando Y; Kodera Y
Oncologist; 2018 Aug; 23(8):919-927. PubMed ID: 30049885
[TBL] [Abstract][Full Text] [Related]
30. Lumbrokinase/paclitaxel nanoparticle complex: potential therapeutic applications in bladder cancer.
Hu B; Yan Y; Tong F; Xu L; Zhu J; Xu G; Shen R
Int J Nanomedicine; 2018; 13():3625-3640. PubMed ID: 29983558
[TBL] [Abstract][Full Text] [Related]
31. Management of Anaplastic Thyroid Carcinoma: the Fruits from the ATC Research Consortium of Japan.
Sugitani I; Onoda N; Ito KI; Suzuki S
J Nippon Med Sch; 2018; 85(1):18-27. PubMed ID: 29540641
[TBL] [Abstract][Full Text] [Related]
32. Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application.
Seca AML; Pinto DCGA
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337925
[TBL] [Abstract][Full Text] [Related]
33. Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.
Gillardin PS; Descamps G; Maiga S; Tessoulin B; Djamai H; Lucani B; Chiron D; Moreau P; Le Gouill S; Amiot M; Pellat-Deceunynck C; Moreau-Aubry A
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295500
[TBL] [Abstract][Full Text] [Related]
34. Codonopis bulleynana Forest ex Diels inhibits autophagy and induces apoptosis of colon cancer cells by activating the NF-κB signaling pathway.
Luan Y; Li Y; Zhu L; Zheng S; Mao D; Chen Z; Cao Y
Int J Mol Med; 2018 Mar; 41(3):1305-1314. PubMed ID: 29286074
[TBL] [Abstract][Full Text] [Related]
35. Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: "a note of caution".
Pelegrina A; Martí J; Miquel R; Ferrer J; Hernández-Gea V; Diaz A; Nadal C; García-Valdecasas JC; Fuster J
World J Surg Oncol; 2017 Dec; 15(1):224. PubMed ID: 29246174
[TBL] [Abstract][Full Text] [Related]
36. Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines.
Sakumoto M; Oyama R; Takahashi M; Takai Y; Kito F; Shiozawa K; Qiao Z; Endo M; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Feb; 54(2):163-176. PubMed ID: 29197033
[TBL] [Abstract][Full Text] [Related]
37. Clinical Management: Metastatic Disease.
Ko AH
Cancer J; 2017; 23(6):355-361. PubMed ID: 29189332
[TBL] [Abstract][Full Text] [Related]
38. Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens.
Chen CA; Chiang CJ; Chen YY; You SL; Hsieh SF; Tang CH; Cheng WF
J Gynecol Oncol; 2018 Jan; 29(1):e16. PubMed ID: 29185274
[TBL] [Abstract][Full Text] [Related]
39. Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study.
Ayhan A; Ozkan NT; Sarı ME; Celik H; Dede M; Akbayır Ö; Güngördük K; Şahin H; Haberal A; Güngör T; Arvas M; Meydanlı MM
J Gynecol Oncol; 2018 Jan; 29(1):e12. PubMed ID: 29185270
[TBL] [Abstract][Full Text] [Related]
40. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment.
Xie Y; Huang L; Chen L; Lin X; Chen L; Zheng Q
World J Surg Oncol; 2017 Nov; 15(1):209. PubMed ID: 29179719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
